Cover Image
Read Now

Drug class review on targeted immune modulators final report

Targeted immune modulators are used in the treatment of certain types of immunologic and inflammatory diseases, including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis. These drugs work...

Full description

Bibliographic Details
Main Author: Gartlehner, Gerald
Corporate Authors: Cecil G. Sheps Center for Health Services Research, RTI International-University of North Carolina Evidence-based Practice Center, Oregon Health & Science University Evidence-based Practice Center, Oregon Health & Science University, Drug Effectiveness Review Project
Format: eBook
Language:English
Published: Portland, Oregon Oregon Health & Science University [2006], 2006
Series:Drug class reviews
Subjects:
Antirheumatic Agents / Therapeutic Use
Drug Evaluation
Antibodies, Monoclonal / Therapeutic Use
Immunologic Factors / Therapeutic Use
Immunoglobulin G / Therapeutic Use
Recombinant Fusion Proteins / Therapeutic Use
Immunoconjugates / Therapeutic Use
Interleukin 1 Receptor Antagonist Protein / Therapeutic Use
Treatment Outcome
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:Targeted immune modulators are used in the treatment of certain types of immunologic and inflammatory diseases, including rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by selectively blocking mechanisms involved in the inflammatory and immune response. The purpose of this review is to help policy makers and clinicians make informed choices about the use of targeted immune modulators
Item Description:Title from PDF title page. - "January 2007."
Physical Description:1 PDF file (148 pages) illustrations

Similar Items